UBS ASSET MANAGEMENT AMERICAS LLC - AVANIR PHARMACEUTICALS INC ownership

AVANIR PHARMACEUTICALS INC's ticker is AVNR and the CUSIP is 05348P401. A total of 108 filers reported holding AVANIR PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 1.25 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS LLC ownership history of AVANIR PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$1,964,000
+61.6%
115,894
+13.7%
0.00%
+100.0%
Q3 2014$1,215,000
+117.4%
101,894
+2.8%
0.00%0.0%
Q2 2014$559,000
+98.2%
99,094
+29.0%
0.00%
Q1 2014$282,000
+60.2%
76,794
+46.3%
0.00%
Q4 2013$176,000
-3.3%
52,494
+22.4%
0.00%
Q3 2013$182,000
-7.6%
42,8940.0%0.00%
Q2 2013$197,00042,8940.00%
Other shareholders
AVANIR PHARMACEUTICALS INC shareholders Q3 2013
NameSharesValueWeighting ↓
Tyrus Capital S.A.M. 2,295,000$38,900,0006.85%
Baker Brothers Advisors 38,513,713$652,807,0006.66%
Realm Partners LLC 300,000$5,085,0003.92%
Miura Global Management 2,758,000$46,748,0003.52%
WATER ISLAND CAPITAL LLC 10,612,846$179,887,740,0003.00%
LONGFELLOW INVESTMENT MANAGEMENT CO LLC 641,056$10,866,0002.72%
Verition Fund Management LLC 703,900$11,931,0002.67%
GLAZER CAPITAL, LLC 1,004,815$17,032,0002.46%
GARDNER LEWIS ASSET MANAGEMENT L P 716,994$12,153,0002.45%
Rock Springs Capital Management LP 1,100,000$18,645,0002.18%
View complete list of AVANIR PHARMACEUTICALS INC shareholders